HIF1A and neoplasm: Hypoxia and activation of the hypoxia-inducible-factor 1A (HIF1-A) pathway is a major effector in tumorogenesis, tumor therapy resistance, epithelial to mesenchymal transition, invasion and metastasis [28,29].